FDA.reportPublic FDA data

olsalazine sodium 250 MG Oral Capsule [Dipentum]

RxCUI
905164
RxNorm name
olsalazine sodium 250 MG Oral Capsule [Dipentum]
Display name
olsalazine sodium 250 MG Oral Capsule [Dipentum]
Full name
olsalazine sodium 250 MG Oral Capsule [Dipentum]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DipentumOLSALAZINE SODIUMViatris Specialty LLC8512d0c6-db4e-4673-b3b4-28975c18413f2024-07-18Warnings, Adverse reactionsExact identifier
rxcui: 905164

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8512d0c6-db4e-4673-b3b4-28975c18413fDipentum 250 MG Oral CapsulePSN15These highlights do not include all the information needed to use DIPENTUM safely and effectively. See full prescribing information for DIPENTUM . DIPENTUM (olsalazine sodium) capsules, for oral use Initial U.S. Approval: 198720240718
8512d0c6-db4e-4673-b3b4-28975c18413fDipentum 250 MG Oral CapsuleSY15These highlights do not include all the information needed to use DIPENTUM safely and effectively. See full prescribing information for DIPENTUM . DIPENTUM (olsalazine sodium) capsules, for oral use Initial U.S. Approval: 198720240718
8512d0c6-db4e-4673-b3b4-28975c18413folsalazine sodium 250 MG Oral Capsule [Dipentum]SBD15These highlights do not include all the information needed to use DIPENTUM safely and effectively. See full prescribing information for DIPENTUM . DIPENTUM (olsalazine sodium) capsules, for oral use Initial U.S. Approval: 198720240718
9dd522a3-587e-44ab-9de3-a0fd079f2ffbDipentum 250 MG Oral CapsulePSN3Pr Dipentum ® (olsalazine sodium) capsule, gelatin coated Rx Only CIP70006A PT#CIA60342 Rev. 1/2014 CIP70006A20171226
9dd522a3-587e-44ab-9de3-a0fd079f2ffbDipentum 250 MG Oral CapsuleSY3Pr Dipentum ® (olsalazine sodium) capsule, gelatin coated Rx Only CIP70006A PT#CIA60342 Rev. 1/2014 CIP70006A20171226
9dd522a3-587e-44ab-9de3-a0fd079f2ffbolsalazine sodium 250 MG Oral Capsule [Dipentum]SBD3Pr Dipentum ® (olsalazine sodium) capsule, gelatin coated Rx Only CIP70006A PT#CIA60342 Rev. 1/2014 CIP70006A20171226
373c321f-cd33-4c11-a2d6-73f38384c27fDipentum 250 MG Oral CapsulePSN2Dipentum (olsalazine sodium capsules) ®20091005
373c321f-cd33-4c11-a2d6-73f38384c27fDipentum 250 MG Oral CapsuleSY2Dipentum (olsalazine sodium capsules) ®20091005
373c321f-cd33-4c11-a2d6-73f38384c27folsalazine sodium 250 MG Oral Capsule [Dipentum]SBD2Dipentum (olsalazine sodium capsules) ®20091005